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ABSTRACT
Non-compliance with anti-epileptic drug treatment results in recurrent seizures and visits to the emergency departments
of the hospitals has been identified as a social and economic problem. The aim of this study was to determine the
prevalence of epileptic patients with non-compliance of anti-epileptic drugs and the understanding of patients living with
epilepsy who presented to the emergency department with seizures. A descriptive study design was employed and the
data-collection tools were a questionnaire for this study. The average age of the study population was 46 years. There was
60% males and 40% females in this study. Non-compliance of anti-epileptic drugs was found to be in 53 patients out of
a total of 225 resulting in the frequency of 23%. Stratification of patients with non-compliance showed that incidence of
non-compliance was more frequent in males since frequency in males was 63% and in females frequency of
non-compliance was only 37%. So major causes of non-compliance should be adressed both in males and females to
manage this diseases in the region.
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INTRODUCTION

others.(2) The frequency of non-compliance was 19% in the
outpatient group as reported in one study. (3) Reasons for
non-compliance are complex and multilayered. Patients
can accidentally fail to adhere through forgetfulness,
misunderstanding, or uncertainty about clinician’s
recommendations, or intentionally due to their own
expectations of treatment, side-effects, and lifestyle
choice. (3) In India, a study relating to doctor-patient
communication and compliance stated that compliance
improved when patients were satisfied with the
consultation process and were asked to recall the
information. Multiple visits to the doctor enhanced
communication, and thus compliant behaviour. (4) Most of
studies have attempted either to identify predictors or to
measure the incidence of non-compliance but there is not
a validated scale for measuring epilepsy patient
non-compliance to antiepileptic drugs. This is especially
true for developing countries including Pakistan. The lack
of these measurements provides difficulties to assess the
impact of specific factors in compliance to treatment.
Services Hospital is the regional hospital in the central
Punjab and serves a huge population of the country. There
is scarcity of published data reporting the prevalence of
epileptic patients with noncompliance of antiepileptic
drugs. In the present study, we have aimed to determine
the prevalence of compliance and non-compliance of
antiepileptic drugs in epileptic patients.

Epilepsy is a chronic condition in which non-compliance is
considered to be a significant problem faced during clinical
treatment. Poor compliance to treatment is one of many
reasons for pharmacological treatment failure and seizure
recurrence. Despite all the best intention and efforts on
the part of the healthcare professionals, those outcomes
might not be achievable if the patients are non-compliant.
(1)
The behavior of compliance depends on specific clinical
situation, nature of the illness, and treatment program.
The effect of recurrent epileptic seizure attacks on the
patient is far reaching. Poor compliance may lead to status
epilepticus, as well as unexpected, sudden death. (2)
Recurrent convulsions can reduce the likelihood of
eventually curing the disorder. With appropriate treatment
and lifestyle changes, the majority of patients diagnosed
with epilepsy will become seizure-free. Compliant
behaviour can be defined as taking anti-epileptic drugs
(AEDs) on time and without fail, not manipulating dosages,
and following the doctor’s advice regarding daily activities.
(2)
Non-compliance is a significant problem in epilepsy
management. As many as 30 to 50% of persons with
epilepsy are non-compliant to the extent of interfering with
their optimal treatment. (2) The effect of non-compliance is
enormous and may lead to an increase in the number of
seizures, medical costs and injury to themselves and
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MATERIALS AND METHODS

Table 2. Gender distribution of all patients included in this
study.

The present study was conducted in OPD (Outpatient
Department) at Services Institute of Medical Sciences and
Services Hospital, Lahore, Pakistan. This 6-month
descriptive study was carried out in 2012 and included a
total of 225 patients who were admitted with the primary
diagnosis of Epilepsy. Male and female patients aged
between 10 to 70 years, who had been diagnosed with
epilepsy at least one year previously, were included.
Patients having other co-morbidities were excludded from
this study. The data-collection tools were a questionnaire
and a structured interview. Patients who were not able to
respond to an interview were also excluded. For each
patient detail history was taken including demographic
information (age, sex, address) and questionnaire was
asked after taking informed consent by researcher herself.
All patients were observed for anti-epilepsy drug
compliance and non-compliance. Patients included in
study, were treated free of cost. Participants gave written
informed consent after the purpose of the study had been
explained to them. The ethics committee of the hospital
approved the study.

Gender
Male
Female
Total

% of all patients

75
60

76.4

45
30
15
0

23.6

Non-compliance

Compliance

Figure 1. Frequency of compliance and non-compliance
of antiepileptic drugs among epileptic patients.

RESULTS

We also identified the gender distribution of epileptic
patients with non-compliance of antiepileptic drugs. The
results have been shown in Table 3 which shows that out
of 53 cases of non-compliance, 33 cases (62.3%) were
male and 20 cases (37.7%) were females (Table 3). This
finding showed that incidence of non-compliance was
more frequent in males as compared to females.

A total of 225 patients fulfilling the inclusion criteria were
enrolled to measure the frequency of noncompliance of
antiepileptic drugs in epileptic patients. Age distribution of
the patients was done which showed that 29.78%
(n=67) were between 10-30 years, 36% (n=81)
between 41-55 years and 34.22% (n=77) were between
56-70 years of age. Average age of the patients was
46.87+5.23 years (Table 1).

Table 3. Stratification for noncompliance of antiepileptic
drugs in epileptic patients with regards to gender.

Table 1. Age distribution of patients included in the study.

Gender
Male
Female
Total

%
29.78
36
34.22
100

(n=53)

No. of patients
33
20
53

%
62.26
37.74
100

DISCUSSION

Mean and SD: 46.87+5.23 (n= 225)

The sole treatment available for the majority of patients
with epilepsy is antiepileptic drug (AED) therapy. Research
has shown that missing or altering antiepileptic drug
dosages can have adverse reactions, that is, increase the

Gender distribution of the patients showed that 59.6%
(n=134) were males and 40.4% (n=91) were females
(Table 2).

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

Frequency of Non-compliance

90

The descriptive statistical analysis included examinations
of means, standard deviations, frequencies, ranges, and
percentages. The statistical packages SPSS (Version 20)
and MS Excel (MS Office 2010) were used.

No. of patients
67
81
77
225

%
59.56
40.44
100

Results regarding the frequency of epileptic patients with
compliance and non-compliance of antiepileptic drugs
have been shown in Figure 1. Figure shows that out of
225 patients, 172 patients (76.4%) had compliance of
antiepileptic drugs. Whereas 53 patients (23.6%) showed
non-compliance to antiepileptic drugs (Figure 1).

Statistical Analyses

Age(in years)
10-30
31-55
56-70
Total

No. of patients
134
91
225
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tremendous implication of poor compliance on clinical
and economic outcomes.

chance of seizure recurrence. For instance, Mattson et al.
reported that over one quarter of seizures occurred at or
before reports of inadequate medication levels. Failure to
follow prescribed drug regimens is known to be fairly
widespread amongst patients with epilepsy: research has
shown that between 25 and 75% fail to adhere, in
particular very young or very old patients, and teenagers.
Given that failing to comply may increase the likelihood of
hospital admission, there could be a potential savings if
compliance could be improved. We planned this study to
determine the most prevalent factors in Pakistan because
demographic, psychosocial, economic factors, literacy
rate is different. Non-compliance of antiepileptic drugs in
epileptic patients leads to recurrent seizures, thus mental
regression occurs (2); by knowing the frequency of
non-compliance, we can adopt some strategies to
over-come this problem to improve levels of compliance
thereby reducing the risk of unnecessary seizures. In this
study, frequency of non-compliance of antiepileptic drugs
in epileptic patients was revealed in 23.56% while
76.44% had no complaint of non-compliance. The
findings of the present study regarding frequency of
non-compliance are in agreement with Hauser et al. (5)
WHO reported that 19% of the patients had
non-compliance in the outpatient group.(5) The evidence
indicates that non-compliance is still common in
healthcare and no substantial change occurred despite
the large number of studies attempting to address and
highlight the problem. In addition, too few studies are
being done systematically to quantify the impact of
non-compliance on health and financial outcomes. The
magnitude of the impact of non-compliance needs to be
studied in future compliance research due to the potential
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CONCLUSION
We concluded that the frequency of noncompliance of
antiepileptic drugs among epileptic patients is higher. This
condition is worsening for males since they showed a
greater percentage of non-compliance as compared to
females. This situation needs special attention of the
physicians while managing epileptic patients.
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